Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma

BACKGROUND: Although sorafenib is accepted as the standard of care in advanced hepatocellular carcinoma (HCC), its therapeutic benefit is marginal. Here, we aimed to compare the efficacy and safety of sorafenib monotherapy (S-M) and sorafenib-based loco-regional treatments (S-LRTs) in advanced HCC....

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sangheun, Kim, Beom Kyung, Kim, Seung Up, Park, Yehyun, Chang, Sooyun, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Chon, Chae Yoon, Han, Kwang-Hyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796498/
https://www.ncbi.nlm.nih.gov/pubmed/24155932
http://dx.doi.org/10.1371/journal.pone.0077240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796498/
https://www.ncbi.nlm.nih.gov/pubmed/24155932
http://dx.doi.org/10.1371/journal.pone.0077240

Ejemplares similares